Priority Date: 20.08.10 (EP 20100173502)

2-(ARYLAMINO)-3H-IMIDAZO[4,5-B]PYRIDINE-6-CARBOXAMIDE DERIVATIVES AND THEIR USE AS MPGES-1 INHIBITORS

  • Application ID: EP11751853
  • Status: APPLICATION DEEMED TO BE WITHDRAWN

Applicant

Attorneys

no operation time available
2 offices
Technology Company
Employment test 51 - 200 employees
Company dna potter clarkson llp
operating since 1889
Headquarter in Nottingham and 1 office
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). Boehringer Ingelheim GmbH and Potter Clarkson LLP are specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 220 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 20.08.2010 - Priority Date (EP 20100173502)
  • 23.02.2012 - Publication A1 (WO2012022792)
  • 26.06.2013 - Publication A1 (EP2606046)

IPC Classification